Answer
Dinutuximab beta is contraindicated in acute grade 3 or 4 graft-versus-host disease or extensive chronic graft-versus-host disease.
Sources for this answer
- Qarziba (Dinutuximab beta)Recordati UK Ltd · emc · SmPC §4.3 Contraindications · Version 13Document updated
Sources checked